Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
10X Genomics Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
TXG
Nasdaq
2836
https://www.10xgenomics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for 10X Genomics Inc
International Markets and 10x Genomics (TXG): A Deep Dive for Investors
- May 6th, 2024 1:08 pm
10x Genomics to Present at the BofA Securities 2024 Healthcare Conference
- May 2nd, 2024 8:05 pm
10x Genomics First Quarter 2024 Earnings: In Line With Expectations
- May 2nd, 2024 10:34 am
10x Genomics, Inc. (NASDAQ:TXG) Q1 2024 Earnings Call Transcript
- May 1st, 2024 3:33 pm
Q1 2024 10X Genomics Inc Earnings Call
- May 1st, 2024 3:05 pm
10x Genomics Inc (TXG) (Q1 2024) Earnings Call Transcript Highlights: Diverse Revenue Streams ...
- May 1st, 2024 7:27 am
10x Genomics (TXG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
- Apr 30th, 2024 10:30 pm
10x Genomics Inc (TXG) Q1 2024 Earnings: Misses Analyst Expectations Amidst New Product Launches
- Apr 30th, 2024 9:43 pm
10x Genomics Reports First Quarter 2024 Financial Results
- Apr 30th, 2024 8:05 pm
The Zacks Analyst Blog Highlights 10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp
- Apr 29th, 2024 11:20 am
3 Medical Products Stocks Set to Beat This Earnings Season
- Apr 26th, 2024 3:30 pm
11 Oversold MidCap Stocks To Buy Now
- Apr 25th, 2024 3:28 pm
Down -23.92% in 4 Weeks, Here's Why 10x Genomics (TXG) Looks Ripe for a Turnaround
- Apr 24th, 2024 1:35 pm
10x Genomics (TXG) Expected to Beat Earnings Estimates: Should You Buy?
- Apr 23rd, 2024 2:01 pm
10x Genomics (TXG) Upgraded to Buy: Here's What You Should Know
- Apr 22nd, 2024 4:00 pm
Bruker to acquire Nanostring for $393M
- Apr 18th, 2024 10:46 am
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024
- Apr 10th, 2024 8:05 pm
10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
- Mar 26th, 2024 1:00 pm
10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel
- Mar 21st, 2024 8:05 pm
10x Genomics Begins Commercial Shipments of Chromium GEM-X Products
- Mar 13th, 2024 8:05 pm
Scroll